Results 21 to 30 of about 21,514 (143)
The Scientific World Journal, 2012 Recent evidence showed the role of peroxisome proliferator-activated receptors (PPARs) in cardiac function. Cardiac contraction induced by various agents is critical in restoring the activity of peroxisome proliferator-activated receptors δ (PPARδ) in ...
Ming-Ting Chou +5 more
doaj +1 more source
Cardiovascular Ultrasound, 2009 D-Ribose, a pentose sugar, has shown to improve myocardial high-energy phosphate stores depleted by ischemia. This study investigated the ability of D-Ribose with low dose dobutamine to improve the contractile response of viable myocardium to dobutamine ...
Gradus-Pizlo Irmina +6 more
doaj +1 more source
Cardiovascular Ultrasound, 2003 Background It has been suggested that an extensive contractile reserve identified recognised by means of dobutamine stress echocardiography may predict a better prognosis in patients with severe left ventricular dysfunction at rest. However, the clinical
Campana Carlo +6 more
doaj +1 more source
Time to re-think the use of dobutamine in sepsis
Journal of Intensive Care, 2017 Dobutamine is commonly used worldwide and included in the protocol for early goal-directed therapy (EGDT). Since the use of dobutamine in EGDT was reported, it has been considered to be an important component, especially in the treatment of septic ...
Ryota Sato, Michitaka Nasu
doaj +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background The optimal choice between balloon‐expandable (BE) and self‐expanding (SE) transcatheter heart valves (THVs) in patients with low‐flow low‐gradient aortic stenosis (LFLG AS) undergoing transcatheter aortic valve replacement (TAVR) remains unclear.
Nav Warraich +10 more
wiley +1 more source
Frontiers in Cardiovascular Medicine, 2015 Background: Low-dose dobutamine stress echocardiography is increasingly used for identifying myocardial viability.Aim: We explored whether dobutamine-induced strain (S) and strain rate (SR) can identify myocardial viability following fibrinolytic therapy
Mohamed eIsmail, Wail eNammas
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Functional assessment of myocardial bridging (MB) remains clinically challenging because of the dynamic nature of the extravascular coronary compression with a certain degree of intraluminal coronary reduction.
Srdjan B. Aleksandric +17 more
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
Dobutamine in paediatric population: a systematic review in juvenile animal models.
PLoS ONE, 2014 ObjectiveAlthough dobutamine is widely used in neonatal clinical practice, the evidence for its use in this specific population is not clear. We conducted a systematic review of the use of dobutamine in juvenile animals to determine whether the evidence ...
Victoria Mielgo +2 more
doaj +1 more source
Peripartum cardiomyopathy – An insight
The Indian Anaesthetists' Forum, 2020 Peripartum cardiomyopathy (PPCM) is a potentially life-threatening disease. However, timely intervention and early detection can save lives. It presents in peripartum period as left ventricular dysfunction and heart failure.
Namita Saraswat +4 more
doaj +1 more source